Standard Biotools Inc
(LAB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,436 | -31,167 | -15,931 | -52,830 | -41,886 |
| Depreciation Amortization | 12,430 | 8,379 | 4,138 | 13,861 | 9,922 |
| Accounts receivable | -3,571 | 843 | 3,096 | -3,393 | 1,650 |
| Accounts payable and accrued liabilities | 702 | 451 | -512 | 107 | 1,453 |
| Other Working Capital | -11,410 | -3,777 | -2,075 | -7,849 | -5,611 |
| Other Operating Activity | 11,956 | 7,642 | 1,484 | 27,481 | 15,374 |
| Operating Cash Flow | $-30,329 | $-17,629 | $-9,800 | $-22,623 | $-19,098 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,545 | -2,310 | -909 | -7,403 | -5,919 |
| Net Acquisitions | N/A | N/A | N/A | -113,190 | -113,190 |
| Purchase Of Investment | -53,704 | -33,731 | N/A | -132,644 | -106,672 |
| Sale Of Investment | 77,319 | 39,376 | 11,100 | 74,852 | 41,744 |
| Purchase Sale Intangibles | -170 | -120 | -120 | N/A | N/A |
| Other Investing Activity | -170 | -120 | -120 | 0 | 0 |
| Investing Cash Flow | $20,900 | $3,215 | $10,071 | $-178,385 | $-184,037 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 195,213 | 195,212 |
| Common Stock Issued | 5,272 | 5,128 | 3,732 | 5,113 | 4,084 |
| Financing Cash Flow | $5,272 | $5,128 | $3,732 | $200,326 | $199,296 |
| Exchange Rate Effect | -739 | -682 | -734 | -866 | -483 |
| Beginning Cash Position | 33,713 | 33,713 | 33,713 | 35,261 | 35,261 |
| End Cash Position | 28,817 | 23,745 | 36,982 | 33,713 | 30,939 |
| Net Cash Flow | $-4,896 | $-9,968 | $3,269 | $-1,548 | $-4,322 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,329 | -17,629 | -9,800 | -22,623 | -19,098 |
| Capital Expenditure | -2,545 | -2,310 | -909 | -7,403 | -5,919 |
| Free Cash Flow | -32,874 | -19,939 | -10,709 | -30,026 | -25,017 |